Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05768711
Title Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR) (AVENHIR)
Acronym AVENHIR
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Groupe Francophone des Myelodysplasies
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.